SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health.
作者信息
Cossarizza Andrea, De Biasi Sara, Guaraldi Giovanni, Girardis Massimo, Mussini Cristina
机构信息
Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Via Campi 287, 41125, Modena, Italy.
Infectious Diseases Clinics, University Hospital, via del Pozzo 71, 41124, Modena, Italy.
出版信息
Cytometry A. 2020 Apr;97(4):340-343. doi: 10.1002/cyto.a.24002. Epub 2020 Mar 18.
Abstract
摘要
相似文献
1
SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health.严重急性呼吸综合征冠状病毒2（SARS-CoV-2），即导致2019冠状病毒病（COVID-19）的病毒：细胞计数法与全球健康面临的新挑战
Cytometry A. 2020 Apr;97(4):340-343. doi: 10.1002/cyto.a.24002. Epub 2020 Mar 18.
2
Lymphopenia during the COVID-19 infection: What it shows and what can be learned.新冠病毒感染期间的淋巴细胞减少症：所呈现的情况及可从中了解到的信息。
Immunol Lett. 2020 Sep;225:31-32. doi: 10.1016/j.imlet.2020.06.013. Epub 2020 Jun 20.
3
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.COVID-19 和 SARS 病例以及未感染对照者的 SARS-CoV-2 特异性 T 细胞免疫。
Nature. 2020 Aug;584(7821):457-462. doi: 10.1038/s41586-020-2550-z. Epub 2020 Jul 15.
4
T cells found in coronavirus patients 'bode well' for long-term immunity.在新冠病毒患者体内发现的T细胞对长期免疫力“预示良好”。
Science. 2020 May 22;368(6493):809-810. doi: 10.1126/science.368.6493.809.
5
New view on older adults with COVID-19: comments on "SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes".关于新冠肺炎老年患者的新观点：对《老年人中的SARS-CoV-2和新冠肺炎：关于发病机制、免疫反应及预后我们可能了解到的情况》的评论
Geroscience. 2020 Oct;42(5):1225-1227. doi: 10.1007/s11357-020-00232-x. Epub 2020 Jul 24.
6
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告：评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
7
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.SARS-CoV-2 感染免疫功能低下患者：体液免疫与细胞免疫。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000862.
8
Inflammatory Cell Infiltration of Adrenals in COVID-19.COVID-19 中的肾上腺炎症细胞浸润。
Horm Metab Res. 2020 Sep;52(9):639-641. doi: 10.1055/a-1191-8094. Epub 2020 Jul 6.
9
The phenotypic changes of γδ T cells in COVID-19 patients.新型冠状病毒肺炎患者 γδ T 细胞的表型变化。
J Cell Mol Med. 2020 Oct;24(19):11603-11606. doi: 10.1111/jcmm.15620. Epub 2020 Aug 30.
10
The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.新型冠状病毒2（SARS-CoV-2）感染与免疫血清学调查的至关重要性。
Eur J Epidemiol. 2020 Apr;35(4):331-333. doi: 10.1007/s10654-020-00635-2. Epub 2020 Apr 21.
引用本文的文献
1
Outcomes of COVID-19 in patients with obinutuzumab compared with patients with rituximab: a retrospective cohort study.奥滨尤妥珠单抗治疗与利妥昔单抗治疗的 COVID-19 患者结局比较：一项回顾性队列研究。
Virol J. 2024 Sep 9;21(1):212. doi: 10.1186/s12985-024-02484-x.
2
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients.免疫衰老与疫苗效力：通过对多发性硬化症患者 SARS-CoV-2 特异性细胞的免疫代谢分析揭示
**请注意**：以上译文仅供参考，具体内容可根据实际情况进行调整。
Nat Commun. 2024 Mar 29;15(1):2752. doi: 10.1038/s41467-024-47013-0.
3
Changes in the innate immune response to SARS-CoV-2 with advancing age in humans.人类随着年龄增长对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的先天性免疫反应的变化。
Immun Ageing. 2024 Mar 21;21(1):21. doi: 10.1186/s12979-024-00426-3.
4
A Correlation Study to Comprehend the SAR-CoV-2 Viral Load, Antiviral Antibody Titer, and Severity of COVID-19 Symptoms Post-infection Amongst the Vaccinated Population in Kamrup District of As sam, Northeast India.一项相关性研究旨在理解在印度东北部阿萨姆邦卡姆鲁普区接种疫苗人群中的 SARS-CoV-2 病毒载量、抗病毒抗体滴度以及感染后 COVID-19 症状的严重程度之间的关系。
Endocr Metab Immune Disord Drug Targets. 2024;24(12):1414-1421. doi: 10.2174/0118715303281124231213110004.
5
Changes in Reaction Time, Balance and Neuroplasticity after Exercise with a Face Mask in Male Adults with Mild COVID-19 Symptoms.轻度新冠肺炎症状成年男性佩戴口罩运动后反应时间、平衡能力和神经可塑性的变化
Healthcare (Basel). 2023 Oct 22;11(20):2800. doi: 10.3390/healthcare11202800.
6
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases.SARS-CoV-2 的结构蛋白和非结构蛋白：COVID-19 治疗或预防相关疾病进展的潜在方面。
Cell Commun Signal. 2023 May 15;21(1):110. doi: 10.1186/s12964-023-01104-5.
7
Role of Wearable Sensing Technology to Manage Long COVID.可穿戴传感技术在管理长新冠中的作用。
Biosensors (Basel). 2022 Dec 31;13(1):62. doi: 10.3390/bios13010062.
8
Gastrointestinal microbiota: A predictor of COVID-19 severity?肠道微生物群：预测 COVID-19 严重程度的指标？
World J Gastroenterol. 2022 Dec 7;28(45):6328-6344. doi: 10.3748/wjg.v28.i45.6328.
9
Biosensors based detection of novel biomarkers associated with COVID-19: Current progress and future promise.基于生物传感器检测与新型冠状病毒肺炎相关的新型生物标志物：当前进展与未来前景。
Biosens Bioelectron X. 2022 Dec;12:100281. doi: 10.1016/j.biosx.2022.100281. Epub 2022 Nov 14.
10
Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia.老年重症 COVID-19 肺炎患者的分子和细胞免疫特征。
Commun Biol. 2022 Jun 16;5(1):590. doi: 10.1038/s42003-022-03537-z.
本文引用的文献
1
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病（COVID-19）患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
2
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
3
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.COVID-19 的免疫反应和潜在疫苗：从 SARS 和 MERS 疫情中吸取的教训。
Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9. doi: 10.12932/AP-200220-0772.
4
An interactive web-based dashboard to track COVID-19 in real time.一个基于网络的交互式仪表盘，用于实时追踪新冠病毒。
Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19.
5
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学：对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
6
First Case of 2019 Novel Coronavirus in the United States.美国首例 2019 新型冠状病毒病例。
N Engl J Med. 2020 Mar 5;382(10):929-936. doi: 10.1056/NEJMoa2001191. Epub 2020 Jan 31.
7
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.德国一名无症状接触者传播2019新型冠状病毒感染
N Engl J Med. 2020 Mar 5;382(10):970-971. doi: 10.1056/NEJMc2001468. Epub 2020 Jan 30.
8
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).流式细胞术和细胞分选在免疫学研究中的应用指南（第二版）。
Eur J Immunol. 2019 Oct;49(10):1457-1973. doi: 10.1002/eji.201970107.
Zotero 插件